Japan Potential Beneficiary Of Europe Economic Crisis, GSK Chief Says
This article was originally published in PharmAsia News
Executive Summary
Japan could be a beneficiary of Europe’s economic crisis as drug makers seek safer markets for their innovative drugs, suggests Andrew Witty, CEO of GlaxoSmithKline.